Australian and New Zealand Germ Cell Trials Group

The Australian and New Zealand Germ Cell Trials Group (ANZGCTG) is a specialized clinical research collaborative dedicated to improving outcomes for patients with germ cell tumors. As a non-profit academic research organization, it coordinates multi-center clinical trials across Australia and New Zealand, often in partnership with the NHMRC Clinical Trials Centre at the University of Sydney. The group's primary focus is on optimizing treatment protocols for testicular cancer, ovarian germ cell tumors, and other rare extragonadal malignancies. ANZGCTG participates in significant international collaborations, such as the TIGER and P3BEP trials, which evaluate advanced chemotherapy regimens and salvage therapies. Their work encompasses the entire clinical trial lifecycle, from study design and regulatory management to data analysis and publication. By integrating clinical expertise with rigorous research methodology, the group has contributed to establishing global standards of care for germ cell cancers.